
Moderna
MRNA · Equities · United States
Price
$207.67
24h change
-
Market cap
$91.2B
Trading hours
24/7 for small sizes
3 ways to own MRNA on Solana
About Moderna
HEALTHCARE · BIOTECHNOLOGY · NASDAQ
Moderna, Inc., a biotechnology company, develops messenger RNA-based vaccines and therapies for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and autoimmune diseases. The company is headquartered in Cambridge, Massachusetts.
Tokenized stocks are issued by third parties and may not be available in your country, including to US persons. Prices come from on-chain markets and can differ from the underlying. Nothing here is financial advice.